+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viscosupplementation System Market 2021-2027

  • ID: 5406830
  • Report
  • July 2021
  • Region: Global
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A
  • Lifecore Biomedical, LLC
  • Regen Lab SA
  • Seikagaku Corp.
  • Stryker Corp.

Global Viscosupplementation System Market Size, Share & Trends Analysis Report by Product (Single-Injection, Three-Injection, and Five-Injection) By Application (Knee, Hip, Ankle, and Others) Forecast 2021-2027.

The global viscosupplementation market is anticipated to grow at a CAGR of around 8.6% during the forecast period. Viscosupplementation is a surgical technique that is used to relieve the effects of osteoarthritis. It is a non-invasive technique that involves injecting lubricating fluid into joints, also known as hyaluronic acid injections. The technique mainly designed to reduce joint pain and improve the condition of osteoarthritis joints such as the knee, hip, foot, shoulder, back, wrist, and elbow. The rising global prevalence of knee osteoarthritis, the demand for minimally invasive procedures, and the growing geriatric population are some key factors that are projected to boost the viscosupplementation market during the forecast period. Furthermore, improved healthcare infrastructure and increased awareness about viscosupplementation are expected to provide significant growth to the global viscosupplementation market. 

On the other hand, the global viscosupplementation market is projected to hinder by stringent government regulations and increasing insurance denials for viscosupplementation products. However, due to the treatment effectiveness in providing relief to patients, the market for viscosupplementation in knee osteoarthritis is rapidly increasing. Patients who didn’t recover from physical exercise, weight loss, or corticosteroid injections will benefit from viscosupplementation for knee procedures. As a result, this will be creating an opportunity for the growth of the market. 

Segmental Outlook 

The global viscosupplementation market is segmented based on product and application. Based on product the market is segmented into single-injection, three-injection, and five-injection. Further on the basis of application, the market is classified into Knee, Hip, Ankle, and others. 

Among product segments, the three-injection segment is projected to have significant growth in the global viscosupplementation market due to the availability of a large number of commercialized goods and a high rate of product adoption. This injection supports treating osteoarthritis, a Knee arthritis is a common form of arthritis that affects many people. It is caused when the cartilage, the smooth lining that covers the bones in the joints, breaks down. This injection is suitable for people who did not get relief from nonsteroidal anti-inflammatory drugs or people who can’t take drugs due to their side effects. 

Regional Outlooks

The global viscosupplementation market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to have a significant share in the global viscosupplementation market due to rising incidences of osteoarthritis in the US and Canada. The growing demand for minimally invasive viscosupplementation procedures for the treatment of knee osteoarthritis is also responsible for the market growth in the region. Furthermore, the existence of advanced healthcare infrastructure, the presence of major key players, and the demand for viscosupplementation products are likely to propel the regional market.

Asia-Pacific is projected to have significant growth in the market during the forecast period. The growth is attributed to the upgrade of healthcare facilities and infrastructure in emerging economies such as China, South Korea, and India. Furthermore, factors such as increased awareness of the effectiveness of viscosupplementation and demand for non-surgical procedures are projected to propel market growth. Furthermore, the relatively low regulatory barriers in South Korea and other emerging countries are expected to draw industry players looking to establish a presence in these emerging markets.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Viscosupplementation market
  • Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where in the market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A
  • Lifecore Biomedical, LLC
  • Regen Lab SA
  • Seikagaku Corp.
  • Stryker Corp.

1. Report Summary
1.1. Research Methods and Tools

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global ViscosupplementationIndustry
  • Recovery Scenario of Global ViscosupplementationIndustry

1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations

3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Viscosupplementation Market by Product
5.1.1. Single-Injection
5.1.2. Three-Injection
5.1.3. Five-Injection
5.2. Global Viscosupplementation Market by Application
5.2.1. Knee
5.2.2. Hip
5.2.3. Ankle
5.2.4. Others(Shoulder, Spine)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Anika Therapeutics, Inc.
7.2. Ferring B.V.
7.3. Fidia Farmaceutici S.p.A
7.4. Johnson & Johnson Services, Inc.
7.5. KalVista Pharmaceuticals, Inc.
7.6. LG Chem (Life Sciences)
7.7. Lifecore Biomedical, LLC
7.8. Maxigen Biotech, Inc.
7.9. Pharmascience Inc.(PendoPharm)
7.10. Regen Lab SA
7.11. Sanofi S.A.
7.12. Seikagaku Corp.
7.13. Shanghai Haohai Biological Technology Co., Ltd.
7.14. Smith & Nephew PLC
7.15. Stellar Pharmaceuticals, Inc.
7.16. Stryker Corp.
7.17. Swiss Biomed Orthopaedics AG
7.18. Virchow Biotech Pvt. Ltd.
7.19. Zimmer Biomet Holdings, Inc.

List of Tables
1. Global Viscosupplementation market research and Analysis by Product,2020-2027 ($ Million)
2. Globalsingle-Injectionviscosupplementationmarket Research and Analysis by Region, 2020-2027($ Million)
3. Global Three-Injectionviscosupplementationmarket research and Analysis by Region, 2020-2027($ Million)
4. Global Five-Injectionviscosupplementation Market Research and Analysis by Region, 2020-2027 ($ Million)
5. Globalviscosupplementation market research and Analysis by Application,
6. Global Viscosupplementation for Knee Market Research and Analysis by Application, 2020-2027($ Million)
7. Globalviscosupplementation for Hip Market Research and Analysis by Region, 2020-2027($ Million)
8. Globalviscosupplementation For ankle market Research and Analysis by Region, 2020-2027 ($ Million)
9. Global Viscosupplementation For others market Research and Analysis by Region, 2020-2027 ($ Million)
10. Global Viscosupplementation Market Research and Analysis by Geography, 2020-2027 ($ Million)
11. North American Viscosupplementation market research and Analysis by Country, 2020-2027 ($ Million)
12. North American Viscosupplementation market research and Analysis Byproduct, 2020-2027 ($ Million)
13. North American Viscosupplementation market research and Analysis by Application, 2020-2027 ($ Million)
14. European Viscosupplementation market research and Analysis by Country, 2020-2027 ($ Million)
15. European Viscosupplementation market research and Analysis by Product, 2020-2027 ($ Million)
16. European Viscosupplementation market research and Analysis by Application, 2020-2027 ($ Million)
17. Asia-Pacific Viscosupplementation market research and Analysis by Country, 2020-2027 ($ Million)
18. Asia-Pacific Viscosupplementation market research and Analysis by Product, 2020-2027 ($ Million)
19. Asia-Pacific Viscosupplementation market research and Analysis by Application, 2020-2027 ($ Million)
20. Rest of the World Viscosupplementation Market Research and Analysis by Region, 2020-2027 ($ Million)
21. Rest of the World Viscosupplementation market research and Analysis by Product 2020-2027 ($ Million)
22. Rest of the World Viscosupplementation Market Research and Analysis by Application, 2020-2027 ($ Million)

List of Figures
1. Impact of COVID-19 on Global Viscosupplementation Market, 2020-2027 (% Million)
2. Impact of COVID-19 on Global Viscosupplementation Market by Segment, 2020-2027 (% Million)
3. Recovery of Global Viscosupplementation Market, 2020-2027 (%)
4. Global Viscosupplementation Marketshare by Product,2020 Vs 2027 (%)
5. Global Viscosupplementation Marketshare by Application, 2020 Vs 2027 (%)
6. Global Viscosupplementation Marketshare by Geography, 2020 Vs 2027 (%)
7. Global Single-Injectionviscosupplementationmarket Share by Geography, 2020 Vs 2027 (%)
8. Global Three-Injectionviscosupplementationmarket Share by Geography, 2020 Vs 2027 (%)
9. Global Five-Injectionviscosupplementationmarket Share by Geography, 2020 Vs 2027 (%)
10. Globalviscosupplementation for Kneemarket Share by Geography, 2020 Vs 2027 (%)
11. Globalviscosupplementation for Hipmarket Share by Geography, 2020 Vs 2027 (%)
12. Globalviscosupplementation Forankle Market Share by Geography, 2020 Vs 2027 (%)
13. Global Viscosupplementation for Others Market Share by Geography, 2020 Vs 2027 (%)
14. Us Viscosupplementation market size, 2020-2027 ($ Million)
15. Canada Viscosupplementation market size, 2020-2027 ($ Million)
16. UK Viscosupplementation and Market Size, 2020-2027 ($ Million)
17. France Viscosupplementation market size, 2020-2027 ($ Million)
18. Germany Viscosupplementation market size, 2020-2027 ($ Million)
19. Italy Viscosupplementation market size, 2020-2027 ($ Million)
20. Spain Viscosupplementation market size, 2020-2027 ($ Million)
21. Rest of Europe Viscosupplementation market size, 2020-2027 ($ Million)
22. India Viscosupplementation market size, 2020-2027 ($ Million)
23. China Viscosupplementation market size, 2020-2027 ($ Million)
24. Japan Viscosupplementation market size, 2020-2027 ($ Million)
25. South Korea Viscosupplementation market size, 2020-2027($ Million)
26. Rest of Asia-Pacific Viscosupplementation market size, 2020-2027 ($ Million)
27. Rest of the World Viscosupplementation market size, 2020-2027 ($ Million)

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Anika Therapeutics, Inc.
  • Ferring B.V.
  • Fidia Farmaceutici S.p.A
  • Johnson & Johnson Services, Inc.
  • KalVista Pharmaceuticals, Inc.
  • LG Chem (Life Sciences)
  • Lifecore Biomedical, LLC
  • Maxigen Biotech, Inc.
  • Pharmascience Inc.(PendoPharm)
  • Regen Lab SA
  • Sanofi S.A.
  • Seikagaku Corp.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Smith & Nephew PLC
  • Stellar Pharmaceuticals, Inc.
  • Stryker Corp.
  • Swiss Biomed Orthopaedics AG
  • Virchow Biotech Pvt. Ltd.
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll